A trial to consider while waiting for the immunotherapy rocket to take off... On clinicaltrials .gov or Chris4Life DATABLUE search for "BBI-608" for active studies. At ASCO-GI last weekend it was a small trial but they saw activity in >50% of heavily pre-treated patients as an add-on to standard chemotherapy, including in patients who had previously failed that chemotherapy.
News Article: http://www.targetedonc.com/conference/2 ... tal-cancer
ASCO-GI Abstract: http://meetinglibrary.asco.org/content/160272-173
-DK